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A B S T R A C T  
Chronic hepatitis has emerged as a grave health crisis in Pakistan that is becoming increasingly difficult to control. The national 
response in the public and private sector is lacking realism, direction and strategy. The aim of the present review was to analyze the 
efforts directed towards elimination of this menace, outline the challenges and make pragmatic recommendations. We searched 
PubMed, Google Scholar and Google web search for relevant indexed literature in English using the Mesh terms ‘Chronic Hepatitis’, 
‘Pakistan’, ‘Hepatitis B’, ‘Hepatitis C’, ‘Hepatitis prevention’, ‘National hepatitis control’, etc. Rigorous efforts to improve the capacity 
of the primary healthcare establishments are pivotal to contain further spread of hepatitis B and C infections. Combating quackery, 
regulating the use of medical sharps and making affordable hepatitis treatment accessible to the masses should be the principal 
focus of the government. Healthcare delivery units should be equipped to render complete coverage of essential quality hepatitis 
services in order to curb this menace. 
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I n t r o d u c t i o n  
The disease burden of chronic hepatitis in Pakistan is one 
of the highest in the world.1 Hepatitis B and C viral 
infections can potentially cause liver cirrhosis and 
hepatocellular carcinoma leading to increased morbidity 
and mortality.2 Viral hepatitis is known as the ‘silent 
epidemic’ because a large number of people are unaware 
that they are infected while the disease is progressively 
causing liver damage.3 In Pakistan 12 million people 
suffer from chronic hepatitis of which 75% suffer from 
hepatitis C and 25% from hepatitis B. Pakistan has the 
second highest global burden of hepatitis C with 8 million 
people infected accounting for 5% of Pakistan’s 
population.4 Every year around 150,000 new cases of 
hepatitis B and C are diagnosed in Pakistan.5 
 
Hepatitis B and C viruses are transmitted through blood 
and body secretions causing acute infections, which clear 
up in 6 months’ time in approximately 80% cases of 
hepatitis B and 20% cases of hepatitis C. The infection 
can acquire chronicity in 20% HBV and 80% HCV cases.6 
Common mode of transmission of the blood-borne 
hepatitis B and C virus in developing countries is the 
reuse of needles and syringes and incorrect sterilization 
of medical instruments. Where as in developed countries 
the routes of transmission are intravenous drug use, 
needle stick injuries, tattooing, sexual intercourse and 
perinatal infections.7 A recombinant vaccine is available 
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for prevention of hepatitis B viral infection while there is 
no vaccine available for hepatitis C viral infection. 
 
Globally, hepatitis caused 1.54 million deaths in 2013, 
showing a substantial increase from 0.89 million deaths in 
1990. The increase in morbidity was noted in the form of 
years lived with disability from 0.65 million in 1990 to 0.87 
million in 2013 and disability adjusted life years (DALY) 
from 31.7 million in 1990 to 42.5 million in 2013. Hepatitis 
B and C are the cause of 96% mortality and 91% of 
DALYs in 2013 because they are chronic infections that 
deteriorate liver function and can potentially cause multi 
organ failure 8 According to World Health Organization, 
worldwide the highest mortality due to hepatitis (i.e. ≥33.5 
deaths per 100 000 population per year) is in the regions 
of Oceania, western sub-Saharan Africa and South Asia. 
Within the Eastern Mediterranean region, Pakistan and 
Egypt bear 80% of disease burden due to hepatitis.9 
 
This is a review article that is corroborating Pakistan’s 
disease burden due to chronic hepatitis. It aims to analyze 
the efforts being employed to eliminate hepatitis B and C 
infections, debunk the actual challenges hindering their 
elimination and make pragmatic recommendations. We 
searched PubMed, Google Scholar and Google web 
search for relevant literature. We used the Mesh terms 
‘Chronic Hepatitis’, ‘Pakistan’, ‘Hepatitis B’, ‘Hepatitis C’, 
‘Hepatitis prevention’, ‘National hepatitis control’, etc. The 
main aim of this literature search was to put in perspective 
the situation of chronic hepatitis in Pakistan and the 
response of the government to this threat. Articles relating 
to the prevalence, modes of transmission, risk factors and 
various community level interventions including both 
governmental and non-governmental response were 
included in this desk review.  Journal articles, government 
reports, non-government organization (NGO) reports, 
newspaper articles, information and reports published by 
international organizations were retrieved from January 
2000 to January 2019. Data was also retrieved from 
Government of Pakistan’s National Hepatitis Control 
Program and other relevant bodies. 
 
National Hepatitis Control Measures 
In order to restrain the burden of chronic hepatitis, efforts 
are being undertaken in the public and private sector of 
Pakistan. Preventive measures which include ensuring 
immunization of children for hepatitis B through the 
Expanded Program of Immunization (EPI) schedule, 
blood screening for safe blood transfusions, free hepatitis 
testing and treatment facilities are being taken by the 
government, private sector and international 
organizations. But these prevention strategies are lacking 
complete coverage; moreover, certain crucial initiatives 
are not being targeted and implemented.  
 
Free hepatitis testing and treatment services are being 
provided in government hospitals of the four provinces of 
Pakistan through the provincial hepatitis prevention and 
control program, however currently there is no integrated 
national hepatitis control program.10 In a public-private 
partnership endeavor the Government of Punjab has 
collaborated with the Pakistan Kidney and Liver Institute 
(PKLI) to provide free testing service and free treatment to 
deserving patients. This program has expanded to 25 
districts of the province of Punjab.11 
 
Pakistan Health Research Council (PHRC, previously 
PMRC) has developed the National Hepatitis Strategy 
Framework which is a 5-year plan (2017 to 2021) with the 
goal to eliminate hepatitis by 2030. This plan has a target 
to reduce HBV and HCV related deaths by 10 % and new 
cases of infection by 30%.12 The new Direct Acting 
Antivirals (DAAs) are now approved by international drug 
regulatory authorities such as Food and Drug 
Administration (FDA) but the cost of these breakthrough 
drugs was extremely high which was a major barrier to 
access. After negotiating with 14 pharmaceutical 
companies the Ministry of National Health Services, 
Regulations and Coordination (NHRC) registered generic 
and branded DAAs.  
 
In 2017, Direct Acting Antiviral (DAA) drug sofosbuvir 
400mg was available for the treatment of Hepatitis C at 
US $15 which is the lowest price in the world.13 This drug 
is being procured by provincial hepatitis control programs 
to dispense free of cost to non-affording patients. 
According to WHO, 95% of people infected with hepatitis 
C can be cured within 2-3 months with the new oral drug 
treatment.14 It seems evident that the epicenter of efforts 
by public and private health sector is on treatment of 
chronic hepatitis, but limited work is being done to 
address the root causes that are leading to uncontrolled 
infection transmission and spread in communities. Focus 
on containing the infection reservoirs through 
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implementation of disease prevention techniques, 
screening and early diagnosis are not the priorities. 
 
Overcoming Challenges in Hepatitis Control 
Due to the frail primary healthcare set up of Pakistan the 
enforcement and implementation of strategies for disease 
prevention is one of the key challenges in stifling the 
spread of hepatitis infection. Screening of high-risk groups 
and timely diagnosis of hepatitis are the stepping stones 
of primary care delivery. According to statistics, 7 million 
people are infected with hepatitis C in Pakistan but only 1 
million (14%) of them are diagnosed. Approximately 4 
million people are infected with hepatitis B but only 0.1 
million (3%) of them are diagnosed.15 Delayed diagnosis 
leads to complications such as chronic liver disease, liver 
cirrhosis and hepatocellular carcinoma. Managing these 
complications in tertiary care hospitals is expensive, 
which is an additional burden on the economy of the 
country. 
 
The government needs to focus on strengthening the 
primary healthcare delivery points; Basic Health Units 
(BHU), Rural Health Centers (RHC) and Tehsil 
Headquarters hospitals (THQ) by promoting hepatitis 
prevention through community outreach campaigns, 
encouraging disease screening and providing rapid 
hepatitis testing kits. It is at these primary cares set ups 
that infected individuals in the catchment population can 
be identified and family mapping can be done to identify 
undiagnosed cases. Proper documentation and follow up 
are crucial in slowing the spread of infection and the 
progression of the disease. Additionally, efforts need to 
be galvanized for ensuring that every child is immunized 
for hepatitis B. Babies who are not delivered in a 
healthcare unit, and are home-delivered in villages, are 
not receiving the hepatitis B vaccination. It is critical to 
ensure that every new born is immunized as per the EPI 
schedule which includes the vaccination for hepatitis B 
(Figure 1).  
 
Although all adult population should be vaccinated for 
hepatitis B but coverage is inadequate particularly in high 
risk groups such as sex workers, transgender population, 
drug addicts and thalassemia patients.16 
 
 
Figure 1. Recommended steps to control spread of Hepatitis B 
and C infection 
 
Interestingly, the major risk factor for hepatitis 
transmission in developed countries is intravenous drug 
use while in Pakistan it is the reuse of syringes for 
unwarranted therapeutic purposes.17 According to a 
survey by Pakistan Medical Research Council, 48% of 
Pakistan’s population is taking less than 5 injections per 
year, 22% are taking between 5-10 injections and 6% are 
taking over 10 injections per person per year.18 The 
Ministry of National Health Services has introduced auto 
disabled syringes to eliminate the reuse of syringes in 
health facilities and by IV drug abusers.19 But 
unfortunately they are not being used in government 
hospitals and other health facilities. Ensuring the use of 
auto disabled syringes and regulating their supply is 
needed to put an end to this major mode of spread for 
hepatitis infection (Figure 1). Furthermore, there is no 
proper guideline and training of staff to manage sharp 
waste disposal and medical waste disposal in public 
hospitals.20 
 
Another significant challenge in the spread of hepatitis is 
that of quackery in urban and rural areas (Figure 1). A 
survey conducted in 2014 showed that there are 200,000 
quacks working in Pakistan.21 The reuse of syringes and 
lack of sterilization in quack clinics including dental clinics 
are key causes of spread of hepatitis infections in the 
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masses. The government should take the local district 
authorities in confidence and conduct crackdown on the 
quack clinics. In addition to this curbing the patient influx 
in these quack clinics is the responsibility of doctors 
working in public and private sector to educate patients 
about the substandard and fraudulent medical practices 
of quacks. Counseling the patients and their families that 
seeking treatment from these quacks will put their health 
at serious risk of contracting harmful infections can prove 
to be very beneficial and reformative. Quacks are 
notorious for administering unwarranted intravenous 
steroids and antibiotics, such subpar treatment regimens 
lead to spread of infectious diseases and cause antibiotic 
resistance. 
 
In Pakistan, pegylated interferon-based therapy is being 
used since the past 10 years for managing hepatitis. The 
new direct acting antiviral drugs such as Sofosbuvir is 
now being used and has shown promising results.22 There 
is an urgent need to speed up the registration and 
availability of new direct acting antivirals for hepatitis in 
the local market. 
 
With the current state of affairs, the national response to 
hepatitis control is unsatisfactory and the prospects of 
eliminating hepatitis by 2030 are bleak. Understanding 
that there is an emergent need to divert attention to the 
core public health issues, in order to reduce morbidity and 
mortality due to hepatitis in Pakistan is of monumental 
importance. Only the government’s unfaltering 
commitment and sound financial investment in this cause 
can pave the way for hepatitis elimination in Pakistan. 
 
Pakistan has a major epidemic of chronic hepatitis B and 
C. The high prevalence and the unchecked spread of 
infection through multiple modes of transmissions is a 
serious threat. In recent years Pakistan has even been 
called a “Cirrhotic State”, which tells a lot about the 
country’s disease landscape. The lack of awareness of 
general public, poorly regulated and unhygienic health 
practices, poor health services and a reactionary 
approach by the government, all add up to make Pakistan 
a perfect incubator for not only chronic hepatitis but also 
other diseases that share similar modes of transmission. 
Robust preventive and curative interventions which are 
resistant to the constantly changing socio-political 
environment of Pakistan are imperative to limit the spread 
of these chronic ailments and their complications. 
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